Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.
Structural Genomics Consortium, University of Toronto, Toronto, Quebec, M5G 1L7, Canada.
F1000Res. 2023 Mar 21;12:308. doi: 10.12688/f1000research.131333.1. eCollection 2023.
Transmembrane protein 106B (TMEM106B), a protein that is localized to the lysosome, is genetically linked to many neurodegenerative diseases and forms fibrils in diseased brains. The reproducibility of TMEM106B research would be enhanced if the community had access to well-characterized anti-TMEM106B antibodies. In this study, we characterized six commercially available TMEM106B antibodies for their performance in Western blot, immunoprecipitation, and immunofluorescence, using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. We identified many high-performing antibodies and encourage readers to use this report as a guide to select the most appropriate antibody for their specific needs.
跨膜蛋白 106B(TMEM106B)是一种定位于溶酶体的蛋白质,与许多神经退行性疾病有关,并在患病大脑中形成纤维。如果研究人员能够获得经过良好特征鉴定的抗 TMEM106B 抗体,那么 TMEM106B 的研究的可重复性将会得到提高。在这项研究中,我们使用基于比较敲除细胞系和同基因亲本对照的读出值的标准化实验方案,对六种市售的 TMEM106B 抗体在 Western blot、免疫沉淀和免疫荧光中的性能进行了表征。我们鉴定出了许多性能较高的抗体,并鼓励读者将本报告用作指南,以选择最适合他们特定需求的抗体。